Molecular differential pathology of rhabdomyosarcoma
- PMID: 2487144
- DOI: 10.1002/gcc.2870010106
Molecular differential pathology of rhabdomyosarcoma
Abstract
Tumors of the soft tissues are classified histogenetically according to their phenotypic resemblance to normal adult tissue. Here we describe molecular approaches that make it possible to distinguish between one class of these tumors, rhabdomyosarcoma, and other small-, round-cell tumors. We show that the ascertainment of specific genotypic changes can be used to distinguish further between the embryonal and alveolar subtypes of rhabdomyosarcoma. We tested our model in two ways: first, in a retrospective analysis of diagnostically problematic cases of undifferentiated, small-cell tumors and, second, in a blind study of pediatric tumors. Rhabdomyosarcoma was correctly identified in all cases using this strategy alone. The underlying simplicity of the strategy used to define rhabdomyosarcoma subtypes with molecular markers suggests a model by which tumors can be unequivocally identified, which may apply equally well to other human solid tumors.
Similar articles
-
Identification of a novel gene NCRMS on chromosome 12q21 with differential expression between rhabdomyosarcoma subtypes.Oncogene. 2002 May 2;21(19):3029-37. doi: 10.1038/sj.onc.1205460. Oncogene. 2002. PMID: 12082533
-
A specific chromosomal abnormality in rhabdomyosarcoma.Cytogenet Cell Genet. 1987;45(3-4):148-55. doi: 10.1159/000132446. Cytogenet Cell Genet. 1987. PMID: 3691179
-
Value of cytogenetics in the differential diagnosis of the small round cell tumors of childhood.Med Pediatr Oncol. 1992;20(2):130-5. doi: 10.1002/mpo.2950200208. Med Pediatr Oncol. 1992. PMID: 1734218
-
[Pathology of childhood and adolescent rhabdomyosarcoma].Pathologe. 1999 Mar;20(2):87-97. doi: 10.1007/s002920050326. Pathologe. 1999. PMID: 10320996 Review. German.
-
Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.Cancer Invest. 2000;18(3):223-41. doi: 10.3109/07357900009031827. Cancer Invest. 2000. PMID: 10754991 Review.
Cited by
-
Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.Genes (Basel). 2021 Sep 25;12(10):1500. doi: 10.3390/genes12101500. Genes (Basel). 2021. PMID: 34680895 Free PMC article. Review.
-
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.Am J Pathol. 1996 Feb;148(2):623-30. Am J Pathol. 1996. PMID: 8579124 Free PMC article.
-
Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.Am J Pathol. 1996 Apr;148(4):1125-38. Am J Pathol. 1996. PMID: 8644855 Free PMC article.
-
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?Br J Cancer. 2001 Sep 14;85(6):831-5. doi: 10.1054/bjoc.2001.2008. Br J Cancer. 2001. PMID: 11556833 Free PMC article.
-
Molecular biology of rhabdomyosarcoma.Clin Transl Oncol. 2007 Jul;9(7):415-9. doi: 10.1007/s12094-007-0079-3. Clin Transl Oncol. 2007. PMID: 17652054 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources